X4 PHARMACEUTICALS, INC
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-70.9M | $-71.5M | $615.0K | $6.2M |
| FY2022 | $-77.1M | $-77.2M | $103.0K | $5.2M |
| FY2023 | $-96.5M | $-96.6M | $60.0K | $8.7M |
| FY2024 | $-130.9M | $-131.2M | $326.0K | $8.2M |
| FY2025 | $-85.6M | $-85.6M | $0 | $4.3M |